Cycuria Wins the SPIRIT Startup Award 2025 in the Health Category

Februar 25, 2025

We are thrilled to announce that Cycuria has been honored with the SPIRIT Startup Award in the Health category ! This prestigious recognition highlights our commitment to pioneering innovation in the biotech space and reinforces our vision of transforming scientific breakthroughs into impactful therapies.

The award ceremony was an inspiring evening, celebrating cutting-edge startups pushing the boundaries of technology, green innovation and healthcare. We are proud to be featured as one of the cover story of the latest SPIRIT magazine , where you can learn more about our journey and vision.

📸 Check out the highlights from the award evening HERE

📖 Read the SPIRIT magazine cover story on Cycuria (in German) HERE

We extend our gratitude to the SPIRIT team, the jury, and our incredible team and supporters who have been part of this journey. Stay tuned for more exciting developments from Cycuria!

Share:

More Posts

Cycuria to Present at the Startup Spotlight at BIO-Europe Spring

Cycuria has been selected to present at the Startup Spotlight Stage during the upcoming BIO-Europe Spring partnering conference! Our presentation will showcase Cycuria’s pioneering approach

Meet Cycuria at ASH Annual Meeting 2024 in San Diego

Cycuria will be attending the upcoming American Society of Hematology (ASH) Annual Meeting in San Diego from December 7- December 10. We look forward to

Cycuria Founder, Prof. Dr. Philipp Jost, Highlights the Strategic Advantages and Opportunities at Medical Science City Graz

We’re thrilled to share recent press coverage highlighting Cycuria Therapeutics‘ innovative approach in oncology and our choice to establish roots in Graz’s Medical Science City,

Cycuria Featured in the Austrian National Newspaper Die Presse

Die Presse, one of Austria’s most respected national newspapers, features our scientific breakthrough in cancer research led by our scientific founder, Prof. Dr. Philipp Jost.